NCT00919737View on ClinicalTrials.gov

Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma Multiforme

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Malignant Glioma
Interventions
DRUG

NPC-08

Polifeprosan 20 with Carmustine 3.85%

Trial Locations (1)

Unknown

The Tazuke Kofukai Foundation Medical Research Kitano Hospital, Osaka

Sponsors

Lead Sponsor

Nobelpharma
All Listed Sponsors
lead

Nobelpharma

INDUSTRY

NCT00919737 - Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma Multiforme | Biotech Hunter | Biotech Hunter